Other researchers have also observed dysregulation in these and other prothrombotic factors (such as F11a and tissue factor, TF) in stable COPD patients, suggesting that this may contribute to an elevated risk of cardiovascular complications [66,81,82]. This evidence concerns the gene F3 and chronic obstructive pulmonary disease.